Advanced Solid Tumors Which Are cMET-dependent research hub

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

This study allows people already getting certain cancer treatments through a Novartis trial to continue their treatment. It looks at how safe and effective these treatments are over a longer time for people with advanced solid tumours, giving them ongoing access to care.